Embody, Inc., a Norfolk, Va.-based medical device company focused on soft tissue repair, closed a $9.3m Series A funding round.
The round was led by Litigit LLC, with participation from Cultivate(MD) and 757 Angels.
The company intends to use the funds to expand its team and the commercial launch Tapestry®, its next-generation soft-tissue repair technology in the second half of 2020.
Led by Jeff Conroy, Co-founder and Chief Executive Officer, Embody is advancing a regenerative platform for the repair of tendon and ligament injuries with novel collagen-based bio-fabrication techniques and products for the sports medicine market.
Founded in 2014 and funded with $20 million in DARPA & DOD funding, the company is developing unique biomaterials with an initial focus on orthopedic applications including Achilles, rotator cuff and knee ligament repair, including ACL (Anterior Cruciate Ligament).